Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Ensysce Biosciences Inc
(NQ:
ENSC
)
0.3739
+0.0039 (+1.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
344,068
Open
0.3700
Bid (Size)
0.3725 (1)
Ask (Size)
0.3745 (2)
Prev. Close
0.3700
Today's Range
0.3501 - 0.3799
52wk Range
0.3550 - 2.060
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
August 29, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Fossil Fuels
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
August 29, 2024
Via
Benzinga
Performance
YTD
-66.32%
-66.32%
1 Month
-12.39%
-12.39%
3 Month
-34.59%
-34.59%
6 Month
-53.50%
-53.50%
1 Year
-79.57%
-79.57%
More News
Read More
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
August 29, 2024
Via
Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
August 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants
August 29, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces IRB Approval for Key MPAR Study
August 27, 2024
Via
ACCESSWIRE
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
August 28, 2024
Via
Benzinga
S&P 500 Edges Higher; American Woodmark Shares Slide
August 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
August 27, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Mixed; ScanSource Reports Weak Q4 Results
August 27, 2024
Via
Benzinga
Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
August 06, 2024
Via
ACCESSWIRE
Ensysce Biosciences Provides Mid-Year 2024 Update
July 23, 2024
Via
ACCESSWIRE
Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
July 09, 2024
Via
ACCESSWIRE
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
June 27, 2024
Via
ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024
August 14, 2024
Via
InvestorPlace
Ensysce Biosciences Reports Second Quarter 2024 Financial Results
August 14, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
June 25, 2024
Via
ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024
June 24, 2024
Via
InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
June 21, 2024
Via
Benzinga
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
June 06, 2024
Via
ACCESSWIRE
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
June 03, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 18, 2024
Via
Benzinga
Ensysce Biosciences Regains Compliance with Nasdaq
May 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.